Sramana Mitra: I want to double click on English as a second language. In March last year, we were in India, and my father took us to see a school in rural West Bengal, quite far from Calcutta, which is the main metropolis in that region. These rural Indian towns and villages are not places where fluent English as a second language is that common. We were blown away by these ninth grade kids who were giving us tours of their labs and their learning process, and they were so enthusiastic, and the whole thing was in fluent English.
>>>
Gus Tai, Investor, Board Member and Retired General Partner at Trinity Ventures, discusses ideas and opportunities in Education with an AI-augmented framework.
>>>
Please post this on your wall in 2025:
“Startups: Do NOT Go to VCs as Beggars. Go as Kings.”
This is the 1Mby1M mantra and it works.
Over 99% of founders chase funding before they are fundable.
Sramana Mitra: What have you been up to in the field of medical imaging? What are you learning? What insights can we convey here?
>>>Sramana Mitra: What is the situation vis-a-vis startup biotech companies that want to use a platform like Atomwise? Is Atomwise seeing startup biotech companies build on their platform?
>>>Sramana Mitra: Could you talk a little bit about the financing journey of a company that has a 10-15 year lifecycle?
>>>Sramana Mitra: So let’s double click down on drug discovery. It’s something that I’ve been spending time on as well. What have you invested in and how are you thinking about AI-enabled drug discovery?
What’s the criteria of what you want to invest in and what have you invested in?
>>>
Mo Islam, Partner at Threshold Ventures. discusses his firm’s AI investment thesis. We had an excellent discussion on AI-enabled drug discovery, AI-enabled medical imaging, etc.
>>>